Neurotrope Alzheimer's drug data fails to impress; shares plunge

(Reuters) - Neurotrope Inc said on Monday the smaller dose of its experimental Alzheimer's drug met the main goal in a small mid-stage study, but shares tumbled 36 percent in premarket trading as investors were not impressed with the data.